DLB vs IMAX
DLB: Dolby Laboratories is a global leader in audio and visual innovation, licensing essential media technologies that power high-quality entertainment experiences in cinemas, homes, and mobile devices. IMAX: IMAX is a global entertainment technology provider delivering immersive cinematic experiences through proprietary large-format projection systems and digital remastering.
Side-by-side fundamentals
| Metric | DLB | IMAX | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $58.45 | $51.31 | |
| Market cap | $5.5B | $2.8B | |
| P/E as of 2026-10-08 | 24.81 | 70.26 | DLB lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | 1.89 | n/a | |
| Net margin FY2025, SEC XBRL | +18.9% | +8.5% | DLB higher |
| Gross margin FY2025, SEC XBRL | +88.1% | +60.0% | DLB higher |
| Operating margin FY2025, SEC XBRL | +19.6% | +20.5% | IMAX higher |
| ROE FY2025, SEC XBRL | +9.7% | +8.2% | DLB higher |
| ROA FY2025, SEC XBRL | +7.9% | +3.9% | DLB higher |
| Debt / equity as of 2026-09-03 | 0.00 | 0.79 | DLB lower |
| Revenue growth (YoY) as of 2026-09-03 | +0.6% | +14.8% | IMAX higher |
| Revenue CAGR (3y) SEC XBRL | +2.5% | +10.9% | IMAX higher |
| Dividend yield as of 2026-09-03 | +2.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 11 | 0 | DLB higher |
| Beta as of 2026-09-03 | 0.75 | 0.49 | |
| 1-year return as of 2026-10-08 close | -17.7% | +59.2% | IMAX higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.